{"id":62630,"date":"2026-06-09T17:02:52","date_gmt":"2026-06-09T08:02:52","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/4564-20260609-01_wp_basic\/"},"modified":"2026-07-12T11:26:01","modified_gmt":"2026-07-12T02:26:01","slug":"4564-20260609-01_wp_basic","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/","title":{"rendered":"Notice Regarding Large-Scale Exercise of the 38th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through Third-Party Allotment"},"content":{"rendered":"","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4564","jir_company_name":"OncoTherapy Science, Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-06-09","jir_source_link":"[Placeholder]","jir_short_summary":"Reporting a large exercise of 38th stock acquisition rights. From June 1 to 9, 9,600,000 shares were issued, with 96,000 exercised (12.06% of total issued), and unexercised rights reduced to 150,000. Unexercised rights at the end of the previous month were 246,000 rights, with total issued shares of 39,864,3700. Future exercise status is unknown.","jir_summary":"### Background and Key Points\nThis notice concerns a large exercise of the 38th stock acquisition rights (with an exercise price adjustment clause) issued through a third-party allocation. The relevant period is June 1\u20139, 2026, with 9,600,000 shares issued; of these, 96,000 rights were exercised (12.06% of total issued). As of now, unexercised rights are 150,000 (15,000,000 shares), down from 246,000 rights (24,600,000 shares) at the end of the prior month.\n\n### Impact on Shareholders and Outlook\nThe large exercise may affect the number of issued shares and potentially dilute shareholders. The trajectory of unexercised rights will depend on future market conditions and the application of the exercise price adjustment clause. Additional disclosures refer to the related notice published on November 21, 2025, and ongoing updates should be monitored.","jir_financial_highlights":"Issued shares: 9,600,000 shares\nNumber of stock options exercised: 96,000 units\nTotal issued shares: 39,864,3700 shares\nUnexercised stock options (as of end of prior month): 246,000 units (24,600,000 shares)\nUnexercised stock options (as of now): 150,000 units (15,000,000 shares)","jir_category":"Other","jir_hashtags":"#OncologyTherapyScience, #IR, #JapaneseStocks","jir_key_figures":"Issued shares: 9,600,000 shares\nNumber of stock options exercised: 96,000 units\nUnexercised stock options (current): 150,000 units (15,000,000 shares)","jir_meta_title":"\u3010OncoTherapy Science\u3011Notice of Large Exercise of Stock Acquisition Rights | June 2026","jir_meta_description":"OncoTherapy Science discloses a large exercise of third-party allotted stock acquisition rights. Issued shares: 9,600,000; unexercised rights reduced to 150,000. Explains impact on shareholders and future outlook.","jir_og_title":"\u3010OncoTherapy Science\u3011Notice of Large Exercise of Stock Acquisition Rights | June 2026","jir_og_description":"Announcement of a large exercise of third-party allotted stock acquisition rights. Issued shares: 9,600,000; unexercised rights reduced to 150,000. Now details inside.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59268,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-62630","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notice Regarding Large-Scale Exercise of the 38th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through Third-Party Allotment - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/\",\"name\":\"Notice Regarding Large-Scale Exercise of the 38th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through Third-Party Allotment - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-09T08:02:52+00:00\",\"dateModified\":\"2026-07-12T02:26:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice Regarding Large-Scale Exercise of the 38th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through Third-Party Allotment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice Regarding Large-Scale Exercise of the 38th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through Third-Party Allotment - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/","url":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/","name":"Notice Regarding Large-Scale Exercise of the 38th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through Third-Party Allotment - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-09T08:02:52+00:00","dateModified":"2026-07-12T02:26:01+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4564\/ir\/4564-20260609-01_wp_basic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Notice Regarding Large-Scale Exercise of the 38th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through Third-Party Allotment"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"59268","title":"\u30aa\u30f3\u30b3\u30bb\u30e9\u30d4\u30fc\u30fb\u30b5\u30a4\u30a8\u30f3\u30b9(\u682a)","ticker":"4564"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/62630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=62630"}],"version-history":[{"count":1,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/62630\/revisions"}],"predecessor-version":[{"id":78878,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/62630\/revisions\/78878"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=62630"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=62630"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=62630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}